Travere Therapeutics, Inc. (NASDAQ:TVTX) Q3 2024 Earnings Call Transcript
Travere Therapeutics, Inc. (NASDAQ:TVTX) Q3 2024 Earnings Call Transcript October 31, 2024Travere Therapeutics, Inc. misses on earnings expectations.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | 56,031,000 | $53,537,621 | 1.51% | ||
2. | 30,000 | $28,598 | 0% | ||
3. | 0 | $0 | -100% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$17.85 | 5,000 | Officer, Director | 245,556 | 2017-06-14 | Filing | |
$15.31 | 5,000 | Director | 52,000 | 2016-03-04 | Filing | |
$8.60 | 15,000 | Director | 35,000 | 2014-11-25 | Filing | |
$8.38 | 6,100 | Director | 129,165 | 2014-11-21 | Filing | |
$8.50 | 8,700 | Officer, Director | 371,756 | 2014-11-21 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$18.30 | 12,090 | 54,927 | 2024-11-25 | Filing | ||
$15.15 | 18,821 | 51,000 | 2024-10-04 | Filing | ||
$14.35 | 21,179 | 69,821 | 2024-10-04 | Filing | ||
$14.06 | 40,000 | 81,000 | 2024-09-30 | Filing | ||
$12.98 | 684 | 61,949 | 2024-09-10 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 3,080,000 | $2,591,204 | 0% | |
2. | Morgan StanleyBOND | 2,834,000 | $2,401,815 | 0% |
3. | Css LlcBOND | 2,500,000 | $2,113,110 | 0.12% |
4. | 30,000 | $25,239 | 0% | |
5. | 0 | $0 | 0% |